{"id":"NCT01399619","sponsor":"Boehringer Ingelheim","briefTitle":"Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)","officialTitle":"Safety and Efficacy of 120mg and 240mg BI 201335 Once Daily in Combination With Pegylated Interferon Alpha and Ribavirin for Treatment of Chronic Hepatitis C (HCV) Genotype 1 Infection in HIV/HCV Co-infected Patients. A Multinational, Randomised, Parallel Group, Open-label Trial.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09","primaryCompletion":"2013-09","completion":"2014-06","firstPosted":"2011-07-22","resultsPosted":"2015-09-04","lastUpdate":"2016-08-29"},"enrollment":310,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C, Chronic"],"interventions":[{"type":"DRUG","name":"PegIFN/RBV","otherNames":[]},{"type":"DRUG","name":"PegIFN/RBV","otherNames":[]},{"type":"DRUG","name":"BI201335","otherNames":[]},{"type":"DRUG","name":"BI201335 24W","otherNames":[]},{"type":"DRUG","name":"PegIFN/RBV","otherNames":[]},{"type":"DRUG","name":"Bi 201335","otherNames":[]}],"arms":[{"label":"BI201335 12W","type":"EXPERIMENTAL"},{"label":"BI 201335 24W","type":"EXPERIMENTAL"},{"label":"BI 201335 24 W","type":"EXPERIMENTAL"}],"summary":"the aim of this trial is to evaluate the efficacy and the safety of BI 201335 given for 12 or 24 weeks in combination with PegIFN/RBV given for 24-48 weeks, according to re-randomisation of Early Treatment Success (ETS) patients at 24 weeks to stop PegIFN/RBV or continue PegIFN/RBV until week 48. If no ETS, then PegIFN/RB for 48 weeks, in HCV treatment-naive or relapsers patients coinfected with HIV","primaryOutcome":{"measure":"Sustained Virological Response (SVR12)","timeFrame":"60 weeks","effectByArm":[{"arm":"Faldaprevir 120mg - 24W","deltaMin":70.7,"sd":null},{"arm":"Faldaprevir 240mg - 12W","deltaMin":78.6,"sd":null},{"arm":"Faldaprevir 240mg - 24W","deltaMin":76.7,"sd":null},{"arm":"Faldaprevir 240mg -T","deltaMin":72.4,"sd":null},{"arm":"Faldaprevir - Total","deltaMin":71.8,"sd":null}],"pValues":[{"comp":"OG004","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":71,"countries":["United States","Brazil","France","Germany","Italy","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["25710287"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":123},"commonTop":["Nausea","Fatigue","Diarrhoea","Headache","Asthenia"]}}